Objective: Objective of this study is to develop delivery-system to overcome BBB by employing novel, non-invasive approach via nasal route.

Background: Alzheimer’s disease(AD), a form of dementia, is progressive, degenerative brain disease characterized by marked atrophy of cerebral cortex and loss of cortical and sub-cortical neurons. Weakening of insulin receptor signaling is involved in ageing-related brain degeneration such as AD. The olfactory neural pathway provides both intraneuronal and extraneuronal pathway into brain. In present study delivery of antibody appended Insulin encapsulated carrier, PEGylatednanoparticle coated with chitosan to facilitate nasal absorption for efficient transfer to brain.

Methods: PEGylated-PLGA nanoparticles were prepared by modified Double Emulsification method and coated with chitosan by freeze drying. Characterization was done by FTIR, NMR and in-vitro for shape, size, and drug-entrapment. In-vivo study comprised biodistribution in various organs and fluorescence microscopy, estimation of Anti-Aβ antibody, PET-Imaging of Brain, Hemolytic Toxicity studies,Histopathology of Nasal Mucosa and Brain with periodic Blood Glucose Level Monitoring.

Results: Nanoparticles were spherical in shape and smooth. Degree of hemolysis showed PEGylated(PEG-NP’s) and chitosan coated nanoparticles(cPEG-NP’s) were less toxic. Blood glucose monitoringindicates reduction in blood glucoselevel in cPEG-NP’s. Biodistributionassessment suggests nanoparticles showedmaximum availability at olfactory bulb entrance. Chitosancoating increased CSF availability of drugeven at initial period of administration. Uptake study shows intensefluorescence in brain revealing higher uptakeof nanoparticles. Thesestudies highlight possible biological significance of cPEG-NP’s for delivery to brain.

Conclusions: Results from various studies suggest nanoparticles are effective delivery system for targeted delivery of insulin in brain for an extended period. Chitosan coating elicits associated benefits in addition to prolonging uptake via intranasal route. This project may provide sound platform towards employment of this modified nanoparticulate carrier for brain delivery of proteins and peptides towards intranasal delivery of insulin for restoration of memory signaling in Alzheimer patients.

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/intranasal-delivery-of-insulin-for-the-restoration-of-memory-signaling-in-alzheimer-disease-2/